Kunihiko Itoh

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AllergyEpidemiological modellingMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Mar 06, 2026
NFE2L2 rs35652124C>T polymorphism predicts Grade 4 neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and fluorouracil chemotherapy: results from exploratory and validation cohorts.

Hisanaga Nomura, Takaya Suzuki, Takashi Kojima

|Sep 27, 2025
Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma.

Keita Hirai, Sekiko Uehara, Toshihiro Shirai

|Apr 29, 2024
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Masahiro Hatori, Daiki Tsuji, Kenichi Suzuki

|Jan 03, 2024
Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.

Takuma Murofushi, Tatsuya Yagi, Daiki Tsuji

|Mar 19, 2021
Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma.

Keita Hirai, Sekiko Uehara, Toshihiro Shirai

Pageof 2

Frequent Collaborators

4 joint publications

Keita Hirai

4 joint publications

Daiki Tsuji

3 joint publications

Toshihiro Shirai

2 joint publications

Yasukata Ohashi